Some aspects of thyroid dysfunction in thalassemia major patients with severe iron overload

被引:0
|
作者
Rindang, Cynthia K. [1 ]
Batubara, Jose R. L. [1 ]
Amalia, Pustika [1 ]
Satari, Hindra [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Med Sch, Dept Child Hlth, Jl Salemba 6, Jakarta, Indonesia
关键词
thalassemia major; endocrine; primary hypothyroidism; iron overload; iron chelation therapy;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Severe iron overload due to recurrent transfusions for chronic anemia and inadequate iron chelation therapy in thalassemia major patients result in various complications, including hypothyroidism. Currently, there has been no data on the prevalence of hypothyroidism in thalassemia major patients at the Thalassemia Centers, Department of Child Health, Cipto Mangunkusumo Hospital (DCH CMH). Objective To study the prevalence of primary hypothyroidism in thalassemia major patients in the Thalassemia Center, DCH MCH. Methods We performed a cross-sectional, descriptive study. All thalassemia major subjects aged 0-18 years with severe iron overload underwent thyroid function examination. Primary hypothyroidism was defined as either normal (compensated) or decreased (decompensated) free T4 (FT4) levels, along with elevated sensitive thyroid-stimulating hormone (TSH) Results 179 subjects enrolled this study with male: female ratio of 1:1.6. The prevalence of primary hypothyroidism in thalassemia major patients with severe iron overload was 26.8% (48/179). Of those 48, 45 had compensated hypothyroidism and 3 had decompensated hypothyroidism, 25.1% and 1.7% of the total subjects, respectively. Compensated hypothyroidism was observed in 17 subjects aged <10 years and in 28 subjects aged >10 years. All 3 decompensated hypothyroidism cases were > 10 years of age. No relationship was found between the occurrence of primary hypothyroidism and mean pre-transfusion Hb levels (P=0.481, OR 1.30; 95% CI 0.63 to 2.68), elevated serum ferritin levels (P-0.74, OR a89; 95% CI 0.46 to L75), and compliance to iron chelation therapy (P=0.570, OR 0.76; 95% CI 0.35 to 1.65). Based on multivariate analysis, only age of < 10 year-old (P=0.029, OR 0.469; 95% CI 0.23 to 0.93) was significantly associated with primary hypothyroidism. Further analysis using receiver operator curve (ROC) technique found that age of 8.5 year-old was the cutoff value to predict the risk of hypothyroidism. Conclusion The prevalence of primary hypothyroidism in our study is high. The occurrence of hypothyroidism is associated with age.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [31] Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
    Zarghamian, Parinaz
    Azarkeivan, Azita
    Arabkhazaeli, Ali
    Mardani, Ahmad
    Shahabi, Majid
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [32] Longitudinal Changes in Iron Overload Parameters and Iron Chelation Therapy in Young Patients with Thalassemia Major
    Kattamis, Antonis
    Stokidis, Konstantinos
    Delaporta, Polyxeni
    Dimitra, Kyriakopoulou
    Petropoulou, Theoni
    Boiu, Sorina
    Ladis, Vassilis
    BLOOD, 2011, 118 (21) : 1383 - 1383
  • [34] Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy
    Duca, Lorena
    Delbini, Paola
    Nava, Isabella
    Cappellini, Maria Domenica
    Meo, Anna
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (01) : 83 - 85
  • [35] Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with β-thalassemia major and iron overload and the subsequent development of hypothyroidism
    Alexandrides, T
    Georgopoulos, N
    Yarmenitis, S
    Vagenakis, AG
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (03) : 319 - 325
  • [36] Iron overload and fragmented QRS in patients with Thalassemia major: Mechanisms, therapies, and new horizons
    Karakulak, Ugur Nadir
    Tutkun, Engin
    Yilmaz, Omer Hinc
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (07): : 592 - 592
  • [37] Serum Metabolite Profiles Are Reflective of Iron Overload in Thalassemia Major Patients on Chelation Therapy
    Sayani, Farzana
    Abdolmohammadi, Niloufar
    Lauf, Anne Marie
    Weljie, Aalim
    BLOOD, 2011, 118 (21) : 925 - 925
  • [38] Cardiac MR images of thalassemia major patients with myocardial iron overload: a data note
    Ali, Emad Shiae
    Bakhshali, Mohamad Amin
    Razavi, Seyed Jafar Shoja
    Poorzand, Hoorak
    Layegh, Parvaneh
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [39] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    Daar, S.
    Pathare, A. V.
    ANNALS OF HEMATOLOGY, 2006, 85 (05) : 315 - 319
  • [40] Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload
    Carpenter, John-Paul
    Alpendurada, Francisco
    Deac, Monica
    Maceira, Alicia
    Garbowski, Maciej
    Kirk, Paul
    Walker, J. Malcolm
    Porter, John B.
    Shah, Farrukh
    Banya, Winston
    He, Taigang
    Smith, Gillian C.
    Pennell, Dudley J.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2010, 12